Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month".
H. Res. 1090 is a nonbinding House resolution expressing support for designating February 2026 as “Low Vision and Vision Impairment Awareness Month.” The resolution is largely commemorative and educational: it cites public health data on the prevalence, cost, and preventability of vision loss, and it highlights the importance of early screening, diagnosis, treatment, and access to eye care for both children and adults. It also emphasizes the role of vision research, assistive devices, and community-based care in preserving independence and quality of life for people with low vision or blindness.
The resolution encourages greater public awareness of eye disease and vision impairment, including conditions such as age-related macular degeneration, glaucoma, cataracts, diabetic retinopathy, refractive errors, amblyopia, and color blindness. It calls for better information sharing with patients, caregivers, and providers, and urges the Secretary of Health and Human Services to support surveillance, research, and convening stakeholders to develop evidence-based tools and information. It also specifically notes the need for child vision screening, follow-up care, and access through community health centers and federally qualified health centers.
Because this is a House resolution, it does not amend state law or federal statutory law and does not create enforceable rights or mandates. Its practical effect is to formally recognize February 2026 as an awareness month and to signal congressional support for public health messaging, surveillance, research, and access to eye care services. The resolution references existing federal programs and entities such as the CDC, CMS, the National Eye Institute, and the Vision and Eye Health Surveillance System, but it does not change their authorities or funding.
The overall sentiment reflected in the bill text is strongly supportive of awareness, prevention, and expanded access to vision care. The resolution presents vision impairment as a significant and costly public health issue and frames early intervention and research as broadly beneficial for children, working-age adults, and older Americans. There is no recorded committee debate or vote history in the provided materials, so no opposing sentiment is documented in the available record.
No explicit controversy appears in the provided materials, and there are no recorded votes or committee transcripts to show disagreement. The only potentially debatable policy themes are the resolution’s emphasis on federal encouragement of surveillance, research, and information dissemination, and its references to access to care through public programs and community health centers. However, because the measure is a symbolic resolution rather than a regulatory or spending bill, the available record does not show identifiable opposition or substantive contention.